DrugPatentWatch Database Preview
GALLIUM DOTATOC GA 68 Drug Profile
» See Plans and Pricing
Which patents cover Gallium Dotatoc Ga 68, and what generic alternatives are available?
Gallium Dotatoc Ga 68 is a drug marketed by Uihc Pet Imaging and is included in one NDA.
The generic ingredient in GALLIUM DOTATOC GA 68 is gallium dotatoc ga-68. There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the gallium dotatoc ga-68 profile page.
Summary for GALLIUM DOTATOC GA 68
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Clinical Trials: | 5 |
| DailyMed Link: | GALLIUM DOTATOC GA 68 at DailyMed |
Generic Entry Opportunity Date for GALLIUM DOTATOC GA 68
Generic Entry Date for GALLIUM DOTATOC GA 68*:
Constraining patent/regulatory exclusivity:
EXCLUSIVITY ON THIS APPLICATION EXPIRING ON THIS DATE HAS BEEN WAIVED BY SPONSOR - SEE SECTION 1.8 OF ORANGE BOOK PREFACE WAIVED EXCLUSIVITY NDA:
Dosage:
SOLUTION;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for GALLIUM DOTATOC GA 68
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institutes of Health (NIH) | N/A |
| Yusuf Menda | N/A |
| National Cancer Institute (NCI) | N/A |
US Patents and Regulatory Information for GALLIUM DOTATOC GA 68
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uihc Pet Imaging | GALLIUM DOTATOC GA 68 | gallium dotatoc ga-68 | SOLUTION;INTRAVENOUS | 210828-001 | Aug 21, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
